CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133,687 | +27.5% | 27,968 | +13.4% | 0.00% | – |
| Q2 2023 | $104,814 | -10.6% | 24,662 | +11.7% | 0.00% | – |
| Q1 2023 | $117,239 | -15.4% | 22,079 | 0.0% | 0.00% | – |
| Q4 2022 | $138,656 | -40.2% | 22,079 | +0.5% | 0.00% | – |
| Q3 2022 | $231,794 | +88.0% | 21,971 | -3.3% | 0.00% | – |
| Q2 2022 | $123,326 | -34.6% | 22,712 | +10.5% | 0.00% | – |
| Q1 2022 | $188,640 | +14.3% | 20,549 | +88.3% | 0.00% | – |
| Q4 2021 | $165,000 | -29.2% | 10,912 | +12.0% | 0.00% | – |
| Q3 2021 | $233,000 | – | 9,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $11,316,000 | 14.13% |
| Memorial Sloan Kettering Cancer Center | 674,196 | $16,093,000 | 10.03% |
| PFM Health Sciences, LP | 4,092,309 | $88,176,000 | 2.59% |
| CloudAlpha Capital Management Limited/Hong Kong | 305,000 | $7,280,000 | 2.15% |
| Monashee Investment Management LLC | 449,377 | $10,727,000 | 1.98% |
| Avidity Partners Management LP | 2,474,067 | $59,056,000 | 1.31% |
| Green Alpha Advisors, LLC | 32,836 | $784,000 | 0.54% |
| Tekla Capital Management LLC | 699,377 | $15,621,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $4,774,000 | 0.40% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 | $70,738,000 | 0.33% |